<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38260018</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1662-4548</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in neuroscience</Title><ISOAbbreviation>Front Neurosci</ISOAbbreviation></Journal><ArticleTitle>The determinants of COVID-induced brain dysfunctions after SARS-CoV-2 infection in hospitalized patients.</ArticleTitle><Pagination><StartPage>1249282</StartPage><MedlinePgn>1249282</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1249282</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnins.2023.1249282</ELocationID><Abstract><AbstractText>The severity of the pandemic and its consequences on health and social care systems were quite diverse and devastating. COVID-19 was associated with an increased risk of neurological and neuropsychiatric disorders after SARS-CoV-2 infection. We did a cross-sectional study of 3 months post-COVID consequences of 178 Cuban subjects. Our study has a unique CUBAN COVID-19 cohort of hospitalized COVID-19 patients and healthy subjects. We constructed a latent variable for pre-health conditions (PHC) through Item Response Theory (IRT) and for post-COVID neuropsychiatric symptoms (Post-COVID-NPS) through Factor Analysis (FA). There seems to be a potential causal relationship between determinants of CIBD and post-COVID-NPS in hospitalized COVID-19 patients. The causal relationships accessed by Structural Equation Modeling (SEM) revealed that PHC (<i>p</i> &lt; 0.001) and pre-COVID cognitive impairments (<i>p</i> &lt; 0.001) affect the severity of COVID-19 patients. The severity of COVID-19 eventually results in enhanced post-COVID-NPS (<i>p</i> &lt; 0.001), even after adjusting for confounders (age, sex, and pre-COVID-NPS). The highest loadings in PHC were for cardiovascular diseases, immunological disorders, high blood pressure, and diabetes. On the other hand, sex (<i>p</i> &lt; 0.001) and pre-COVID-NPS including neuroticism (<i>p</i> &lt; 0.001), psychosis (<i>p</i> = 0.005), cognition (<i>p</i> = 0.036), and addiction (<i>p</i> &lt; 0.001) were significantly associated with post-COVID-NPS. The most common neuropsychiatric symptom with the highest loadings includes pain, fatigue syndrome, autonomic dysfunctionalities, cardiovascular disorders, and neurological symptoms. Compared to healthy people, COVID-19 patients with pre-health comorbidities or pre-neuropsychiatric conditions will have a high risk of getting severe COVID-19 and long-term post-COVID neuropsychiatric consequences. Our study provides substantial evidence to highlight the need for a complete neuropsychiatric follow-up on COVID-19 patients (with severe illness) and survivors (asymptomatic patients who recovered).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Yasir, Jin, Razzaq, Caballero-Moreno, Gal&#xe1;n-Garc&#xed;a, Ren, Valdes-Sosa, Rodriguez-Labrada, Bringas-Vega and Valdes-Sosa.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yasir</LastName><ForeName>Shahwar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Joint China-Cuba Laboratory for Neurotechnology and Bioengineering (JCCLNB), The Clinical Hospital of Chengdu Brain Science Institute, School of Life Sciences and Technology, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jin</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Joint China-Cuba Laboratory for Neurotechnology and Bioengineering (JCCLNB), The Clinical Hospital of Chengdu Brain Science Institute, School of Life Sciences and Technology, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razzaq</LastName><ForeName>Fuleah A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Joint China-Cuba Laboratory for Neurotechnology and Bioengineering (JCCLNB), The Clinical Hospital of Chengdu Brain Science Institute, School of Life Sciences and Technology, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caballero-Moreno</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Psiquiatria Galigarcia, Hospital Nacional, La Habana, Cuba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gal&#xe1;n-Garc&#xed;a</LastName><ForeName>Lidice</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Cuban Neuroscience Center, La Habana, Cuba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Joint China-Cuba Laboratory for Neurotechnology and Bioengineering (JCCLNB), The Clinical Hospital of Chengdu Brain Science Institute, School of Life Sciences and Technology, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdes-Sosa</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Cuban Neuroscience Center, La Habana, Cuba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Labrada</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Cuban Neuroscience Center, La Habana, Cuba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bringas-Vega</LastName><ForeName>Maria L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Joint China-Cuba Laboratory for Neurotechnology and Bioengineering (JCCLNB), The Clinical Hospital of Chengdu Brain Science Institute, School of Life Sciences and Technology, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Cuban Neuroscience Center, La Habana, Cuba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdes-Sosa</LastName><ForeName>Pedro A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Joint China-Cuba Laboratory for Neurotechnology and Bioengineering (JCCLNB), The Clinical Hospital of Chengdu Brain Science Institute, School of Life Sciences and Technology, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Cuban Neuroscience Center, La Habana, Cuba.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurosci</MedlineTA><NlmUniqueID>101478481</NlmUniqueID><ISSNLinking>1662-453X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">neuropsychology</Keyword><Keyword MajorTopicYN="N">post-COVID neuropsychiatric symptoms/disorders</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>10</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38260018</ArticleId><ArticleId IdType="pmc">PMC10800467</ArticleId><ArticleId IdType="doi">10.3389/fnins.2023.1249282</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adab P., Haroon S., O&#x2019;Hara M. E., Jordan R. E. (2022). Comorbidities and covid-19. BMJ 377:o1431. 10.1136/bmj.o1431</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1431</ArticleId><ArticleId IdType="pubmed">35705219</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. (2022). Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28 1461&#x2013;1467. 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., et al. (2021). Post-COVID syndrome in non-hospitalized patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg. Health Europe 6:100122. 10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch J. B., Rengasamy E. R., Watson C., Jansen K., Chakraborty S., Sundaram R. D., et al. (2022). Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun. 4:fcab297. 10.1093/braincomms/fcab297</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Beran T. N., Violato C. (2010). Structural equation modeling in medical research: a primer. BMC Res. Notes 3:267. 10.1186/1756-0500-3-267</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-3-267</ArticleId><ArticleId IdType="pmc">PMC2987867</ArticleId><ArticleId IdType="pubmed">20969789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigdelou B., Sepand M. R., Najafikhoshnoo S., Negrete J. A. T., Sharaf M., Ho J. Q., et al. (2022). COVID-19 and Preexisting Comorbidities: risks, synergies, and clinical outcomes. Front. Immunol. 13:890517. 10.3389/fimmu.2022.890517</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.890517</ArticleId><ArticleId IdType="pmc">PMC9196863</ArticleId><ArticleId IdType="pubmed">35711466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourmistrova N. W. (2022). Long-term effects of COVID-19 on mental health: a systematic review. J. Affect. Disord. 299 118&#x2013;125. 10.1016/j.jad.2021.11.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.11.031</ArticleId><ArticleId IdType="pmc">PMC8758130</ArticleId><ArticleId IdType="pubmed">34798148</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourmistrova N. W., Solomon T., Braude P., Strawbridge R., Carter B. (2022). Long-term effects of COVID-19 on mental health: a systematic review. J. Affect. Disord. 299 118&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8758130</ArticleId><ArticleId IdType="pubmed">34798148</ArticleId></ArticleIdList></Reference><Reference><Citation>Busatto G. F., De Araujo A. L., Castaldelli-Maia J. M., Damiano R. F., Imamura M., Guedes B. F., et al. (2022). Post-acute sequelae of SARS-CoV-2 infection: relationship of central nervous system manifestations with physical disability and systemic inflammation. Psychol. Med. 52 2387&#x2013;2398. 10.1017/S0033291722001374</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291722001374</ArticleId><ArticleId IdType="pmc">PMC9151630</ArticleId><ArticleId IdType="pubmed">35521752</ArticleId></ArticleIdList></Reference><Reference><Citation>Calixto-Calder&#xf3;n B., V&#xe1;zquez-Gonz&#xe1;lez M. F., Mart&#xed;nez Pel&#xe1;ez R., Bermeo-Escalona J. R., Garc&#xed;a V., Mena L. J., et al. (2021). Pre-existing comorbidity, the highest risk factor for poor prognosis of COVID-19 among the Mexican population. Nova Sci. 13.</Citation></Reference><Reference><Citation>Castro V. M., Rosand J., Giacino J. T., McCoy T. H., Perlis R. H. (2021). Case-control study of neuropsychiatric symptoms following COVID-19 hospitalization in 2 academic health systems [Preprint]. Psychiatry Clin. Psychol. 10.1101/2021.07.09.2125235</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.09.2125235</ArticleId><ArticleId IdType="pmc">PMC9199464</ArticleId><ArticleId IdType="pubmed">35705635</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko M., Job A., Caston F., George P., Yacoub A., C&#xe1;ceda R. (2020). COVID-19-induced psychosis and suicidal behavior: case report. SN Compr. Clin. Med. 2 2391&#x2013;2395. 10.1007/s42399-020-00530-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00530-7</ArticleId><ArticleId IdType="pmc">PMC7519695</ArticleId><ArticleId IdType="pubmed">33015547</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers R. P. (2012). mirt: A multidimensional item response theory package for the R environment. J. Stat. Softw. 48, 1-29. 10.18637/jss.v048.i06</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v048.i06</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R., Yen-Ting Chen T., Wang S.-I., Hung Y.-M., Chen H.-Y., Wei C.-C. J. (2023). Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study. EClinicalMedicine 56:101783. 10.1016/j.eclinm.2022.101783</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101783</ArticleId><ArticleId IdType="pmc">PMC9830133</ArticleId><ArticleId IdType="pubmed">36643619</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlton E., Nainar F., Reyes-Beaman S. (2021). Neuropsychiatric disorders and COVID-19. Lancet Psychiatry 8:563. 10.1016/S2215-0366(21)00177-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00177-2</ArticleId><ArticleId IdType="pmc">PMC8216630</ArticleId><ArticleId IdType="pubmed">34147172</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilazi M., Duffy E. Y., Thakkar A., Michos E. D. (2021). COVID and cardiovascular disease: what we know in 2021. Curr. Atheroscler. Rep. 23:37. 10.1007/s11883-021-00935-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-021-00935-2</ArticleId><ArticleId IdType="pmc">PMC8117457</ArticleId><ArticleId IdType="pubmed">33983522</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. (2022). Unexplained post-acute infection syndromes. Nat. Med. 28 911&#x2013;923. 10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham J. W., Vaduganathan M., Claggett B. L., Jering K. S., Bhatt A. S., Rosenthal N., et al. (2021). Clinical outcomes in young us adults hospitalized with COVID-19. JAMA Internal Med. 181:379. 10.1001/jamainternmed.2020.5313</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.5313</ArticleId><ArticleId IdType="pmc">PMC7489373</ArticleId><ArticleId IdType="pubmed">32902580</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S. E., Guo Y., Heath K., Dasmari&#xf1;as M. C., Jubilo K. G., Samranvedhya J., et al. (2021). Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 373:n1098. 10.1136/bmj.n1098</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., Assaf G. S., McCorkell L., Wei H., Low R. J., Re&#x2019;em Y., et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., McCorkell L., Vogel J. M., Topol E. J. (2023). Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21 133&#x2013;146. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>De Berardis D., Di Carlo F., Di Giannantonio M., Pettorruso M. (2022). Legacy of neuropsychiatric symptoms associated with past COVID-19 infection: a cause of concern. World J. Psychiatry 12 773&#x2013;778. 10.5498/wjp.v12.i6.773</Citation><ArticleIdList><ArticleId IdType="doi">10.5498/wjp.v12.i6.773</ArticleId><ArticleId IdType="pmc">PMC9258273</ArticleId><ArticleId IdType="pubmed">35978974</ArticleId></ArticleIdList></Reference><Reference><Citation>De Erausquin G. A., Snyder H., Brugha T. S., Seshadri S., Carrillo M., Sagar R., et al. (2022). Chronic neuropsychiatric sequelae of SARS-CoV-2: protocol and methods from the Alzheimer&#x2019;s Association Global Consortium. Alzheimers Dement. Transl. Res. Clin. Interv. 8:e12348. 10.1002/trc2.12348</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12348</ArticleId><ArticleId IdType="pmc">PMC9494609</ArticleId><ArticleId IdType="pubmed">36185993</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., et al. (2022). SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604 697&#x2013;707. 10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Edison P. (2021a). Brain connectivity: evaluating neurological complications in COVID-19. Brain Connect. 11 692&#x2013;694. 10.1089/brain.2021.29028.ped</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/brain.2021.29028.ped</ArticleId><ArticleId IdType="pubmed">34762501</ArticleId></ArticleIdList></Reference><Reference><Citation>Edison P. (2021b). COVID-19, network dysfunction and neurodegeneration. Brain Connect. 11 785&#x2013;787. 10.1089/brain.2021.29030.ped</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/brain.2021.29030.ped</ArticleId><ArticleId IdType="pubmed">34889649</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V., Stefanou M. I., Demetriou M., Siafakas N., Makris M., Tsivgoulis G., et al. (2022). Long COVID and neuropsychiatric manifestations (Review). Exp. Ther. Med. 23:363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst A. F., Albers C. J. (2017). Regression assumptions in clinical psychology research practice&#x2014;A systematic review of common misconceptions. PeerJ 5:e3323. 10.7717/peerj.3323</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.3323</ArticleId><ArticleId IdType="pmc">PMC5436580</ArticleId><ArticleId IdType="pubmed">28533971</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahriani M., Ilmawan M., Fajar J. K., Maliga H. A., Frediansyah A., Masyeni S., et al. (2021). Persistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis&#x2014;A systematic review and meta-analysis. Narra J. 1:e36. 10.52225/narraj.v1i2.36</Citation><ArticleIdList><ArticleId IdType="doi">10.52225/narraj.v1i2.36</ArticleId><ArticleId IdType="pmc">PMC10914031</ArticleId><ArticleId IdType="pubmed">38449463</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Cuadrado M. L., Florencio L. L. (2021). Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int. J. Environ. Res. Public Health 18:2621. 10.3390/ijerph18052621</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J. A., Simon N. M. (2022). Bridging knowledge gaps in the diagnosis and management of neuropsychiatric sequelae of COVID-19. JAMA Psychiatry 79:811. 10.1001/jamapsychiatry.2022.1616</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.1616</ArticleId><ArticleId IdType="pubmed">35767287</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E. (2021). 18F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging 48 2823&#x2013;2833. 10.1007/s00259-021-05215-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzm&#xe1;n M. G., P&#xe9;rez L., Tejero Y., Mederos D., Aguado M. E., Pintos Y., et al. (2022). Emergence and evolution of SARS-CoV-2 genetic variants during the Cuban epidemic. J. Clin. Virol. Plus 2:100104. 10.1016/j.jcvp.2022.100104</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcvp.2022.100104</ArticleId><ArticleId IdType="pmc">PMC9394106</ArticleId><ArticleId IdType="pubmed">36034515</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S. R., Jolly A., Grant J. E., Patrick F., et al. (2020). Cognitive deficits in people who have recovered from COVID-19 relative to controls: an N=84,285 online study. Psychiatry Clin. Psychol. [preprint]. 10.1101/2020.10.20.20215863</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.20.20215863</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Meziani F. (2020). Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med. 382 2268&#x2013;2270. 10.1056/NEJMc2008597</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. (2023). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 401 e21&#x2013;e33. 10.1016/S0140-6736(23)00810-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00810-3</ArticleId><ArticleId IdType="pmc">PMC10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Li X., Gu X., Zhang H., Ren L., Guo L., et al. (2022). Health outcomes in people 2 years after surviving hospitalization with COVID-19: a longitudinal cohort study. Lancet Respir. Med. 10 863&#x2013;876. 10.1016/S2213-2600(22)00126-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi R. M., Lupi L., Zaccone G., Italia L., Raffo M., Tomasoni D., et al. (2020). Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5 819&#x2013;824. 10.1001/jamacardio.2020.1096</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1096</ArticleId><ArticleId IdType="pmc">PMC7364333</ArticleId><ArticleId IdType="pubmed">32219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Yasir S., Razzaq F. A., Calzada A., Virues T., Caballero A., et al. (2023). qEEG mediates the effect of infection severity on COVID-induced brain dysfunction. Int. J. Psychophysiol. 188 46&#x2013;47. 10.1016/j.ijpsycho.2023.05.118</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpsycho.2023.05.118</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorgensen T. D., Pornprasertmanit S., Schoemann A. M., Rosseel Y. (2022). \textttsemTools: useful tools for structural equation modeling. Available online at: https://CRAN.R-project.org/package=semTools
(accessed April 28, 2023)</Citation></Reference><Reference><Citation>Kompaniyets L., Pennington A. F., Goodman A. B., Rosenblum H. G., Belay B., Ko J. Y., et al. (2021). Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020&#x2013;March 2021. Prev. Chronic Dis. 18:210123. 10.5888/pcd18.210123</Citation><ArticleIdList><ArticleId IdType="doi">10.5888/pcd18.210123</ArticleId><ArticleId IdType="pmc">PMC8269743</ArticleId><ArticleId IdType="pubmed">34197283</ArticleId></ArticleIdList></Reference><Reference><Citation>Komsta L., Novomestky F. (2022). moments: moments, cumulants, skewness, kurtosis and related tests. Available online at: https://CRAN.R-project.org/package=moments
(accessed April 25, 2023)</Citation></Reference><Reference><Citation>Kumar S., Veldhuis A., Malhotra T. (2021). Neuropsychiatric and cognitive sequelae of COVID-19. Front. Psychol. 12:577529. 10.3389/fpsyg.2021.577529</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2021.577529</ArticleId><ArticleId IdType="pmc">PMC7960660</ArticleId><ArticleId IdType="pubmed">33737894</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyzar E. J., Purpura L. J., Shah J., Cantos A., Nordvig A. S., Yin M. T. (2021). Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up. Brain Behav. Immun. Health 16:100315. 10.1016/j.bbih.2021.100315</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100315</ArticleId><ArticleId IdType="pmc">PMC8321961</ArticleId><ArticleId IdType="pubmed">34345869</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam M. H.-B. (2009). Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch. Internal Med. 169:2142. 10.1001/archinternmed.2009.384</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K., Kristoffersen D. T., Dell&#x2019;Isola A., Kiadaliri A., Turkiewicz A., Runhaar J., et al. (2022). Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat. Commun. 13:7363. 10.1038/s41467-022-35240-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35240-2</ArticleId><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. (2021). Covid and the brain: researchers zero in on how damage occurs. Nature 595 484&#x2013;485. 10.1038/d41586-021-01693-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01693-6</ArticleId><ArticleId IdType="pubmed">34234323</ArticleId></ArticleIdList></Reference><Reference><Citation>Moshagen M., Bader M. (2023). semPower: power analyses for SEM. Available online at: https://CRAN.R-project.org/package=semPower
(accessed April 25, 2023)</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Desai A. D., Wan E. Y. (2023). Post-COVID-19 condition. Annu. Rev. Med. 74 55&#x2013;64. 10.1146/annurev-med-043021-030635</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-030635</ArticleId><ArticleId IdType="pubmed">35914765</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M. V., McGroder C., Stevens J. S., et al. (2021). Post-acute COVID-19 syndrome. Nat. Med. 27 601&#x2013;615. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan M. S., Bertolino L., Zampino R., Durante-Mangoni E. Monaldi Hospital Cardiovascular Infection Study Group (2021). Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review. Clin. Microbiol. Infect. 27 1250&#x2013;1261. 10.1016/j.cmi.2021.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.06.015</ArticleId><ArticleId IdType="pmc">PMC8220864</ArticleId><ArticleId IdType="pubmed">34171458</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D. A., L&#xfc;scher T. F., Neubauer S. (2022). Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 43 1157&#x2013;1172. 10.1093/eurheartj/ehac031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud-Charest O., Lui L. M. W., Eskander S., Ceban F., Ho R., Di Vincenzo J. D., et al. (2021). Onset and frequency of depression in post-COVID-19 syndrome: a systematic review. J. Psychiatr. Res. 144 129&#x2013;137. 10.1016/j.jpsychires.2021.09.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.09.054</ArticleId><ArticleId IdType="pmc">PMC8482840</ArticleId><ArticleId IdType="pubmed">34619491</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson T. G., Fang S., Mitchell R. E., Holmes M. V., Davey Smith G. (2021). Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to severe SARS-CoV-2. EBioMedicine 64:103228. 10.1016/j.ebiom.2021.103228</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103228</ArticleId><ArticleId IdType="pmc">PMC7857697</ArticleId><ArticleId IdType="pubmed">33548839</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J. P., Chesney E., Oliver D., Pollak T. A., McGuire P., Fusar-Poli P., et al. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 7 611&#x2013;627. 10.1016/S2215-0366(20)30203-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell C. D., Lone N. I., Baillie J. K. (2023). Comorbidities, multimorbidity and COVID-19. Nat. Med. 29 334&#x2013;343. 10.1038/s41591-022-02156-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02156-9</ArticleId><ArticleId IdType="pubmed">36797482</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampogna G., Di Vincenzo M., Giallonardo V., Perris F., Volpicelli A., Del Vecchio V., et al. (2022). The psychiatric consequences of long-COVID: a scoping review. J. Pers. Med. 12:1767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9697474</ArticleId><ArticleId IdType="pubmed">36579511</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyaolu A., Okorie C., Marinkovic A., Patidar R., Younis K., Desai P., et al. (2020). Comorbidity and its Impact on Patients with COVID-19. SN Compr. Clin. Med. 2 1069&#x2013;1076. 10.1007/s42399-020-00363-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00363-4</ArticleId><ArticleId IdType="pmc">PMC7314621</ArticleId><ArticleId IdType="pubmed">32838147</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou T. M., Joca S., Wegener G., Bay-Richter C. (2021). Psychiatric and neuropsychiatric sequelae of COVID-19 &#x2013; A systematic review. Brain Behav. Immun. 97 328&#x2013;348. 10.1016/j.bbi.2021.07.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;tzwohl M., Kallert T., Jurjanz L. (2007). Using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN 2.1) as a diagnostic interview providing dimensional measures: cross-national findings on the psychometric properties of psychopathology scales. Eur. Psychiatry 22 229&#x2013;238. 10.1016/j.eurpsy.2006.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eurpsy.2006.10.005</ArticleId><ArticleId IdType="pubmed">17188845</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharun K., Tiwari R., Yatoo M. I., Natesan S., Megawati D., Singh K. P., et al. (2022). A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19. Narra J. 2:e92. 10.52225/narra.v2i3.92</Citation><ArticleIdList><ArticleId IdType="doi">10.52225/narra.v2i3.92</ArticleId><ArticleId IdType="pmc">PMC10914132</ArticleId><ArticleId IdType="pubmed">38449903</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G. B., B&#xfc;ttiker P., Weissenberger S., Ptacek R., Wang F., Esch T., et al. (2022). Biomedical perspectives of acute and chronic neurological and neuropsychiatric sequelae of COVID-19. Curr. Neuropharmacol. 20 1229&#x2013;1240. 10.2174/1570159X20666211223130228</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X20666211223130228</ArticleId><ArticleId IdType="pmc">PMC9886822</ArticleId><ArticleId IdType="pubmed">34951387</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K., et al. (2022). Assessment of 115 symptoms for Long COVID (post-COVID-19 condition) and their risk factors in non-hospitalized individuals: a retrospective matched cohort study in UK primary care. Res. Square [preprint]. 10.21203/rs.3.rs-1343889/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1343889/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C. H., Murray B., Varsavsky T., Graham M. S., Penfold R. S., Bowyer R. C., et al. (2021). Attributes and predictors of long COVID. Nat. Med. 27 626&#x2013;631. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabachnick B. G., Linda S. F., Ullman J. B. (2007). Using multivariate statistics, Vol. 5. Boston, MA: Pearson. 10.1515/snde-2014-0102</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/snde-2014-0102</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansey C. M. (2007). One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch. Internal Med. 167:1312. 10.1001/archinte.167.12.1312</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.12.1312</ArticleId><ArticleId IdType="pubmed">17592106</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J. R., Husain M., Luciano S., Harrison P. J. (2021). 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8 416&#x2013;427. 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., et al. (2022). Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry 9 815&#x2013;827. 10.1016/S2215-0366(22)00260-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Skorniewska Z., Hampshire A., Chalmers J. D., Ho L.-P., Horsley A., et al. (2023). Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization. Nat. Med. 29 2498&#x2013;2508. 10.1038/s41591-023-02525-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02525-y</ArticleId><ArticleId IdType="pmc">PMC10579097</ArticleId><ArticleId IdType="pubmed">37653345</ArticleId></ArticleIdList></Reference><Reference><Citation>Treskova-Schwarzbach M., Haas L., Reda S., Pilic A., Borodova A., Karimi K., et al. (2021). Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med. 19:212. 10.1186/s12916-021-02058-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02058-6</ArticleId><ArticleId IdType="pmc">PMC8390115</ArticleId><ArticleId IdType="pubmed">34446016</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdes-Sosa P. A., Evans A. C., Valdes-Sosa M. J., Poo M. (2021). A call for international research on COVID-19-induced brain dysfunctions. Natl. Sci. Rev. 8:nwab190. 10.1093/nsr/nwab190</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwab190</ArticleId><ArticleId IdType="pmc">PMC8574484</ArticleId><ArticleId IdType="pubmed">34984105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan E. Y. F., Mathur S., Zhang R., Yan V. K. C., Lai F. T. T., Chui C. S. L., et al. (2023). Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank. Cardiovasc. Res. 119 1718&#x2013;1727. 10.1093/cvr/cvac195</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac195</ArticleId><ArticleId IdType="pubmed">36652991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei T., Simko V. (2021). R package &#x201c;corrplot&#x201d; visualization of a correlation matrix. Available online at: https://github.com/taiyun/corrplot
(accessed May 05, 2023)</Citation></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., Riley S., Darzi A., Cooke G., et al. (2022). Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 13:1957. 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H., Averick M., Bryan J., Chang W., McGowan L. D., Fran&#xe7;ois R., et al. (2019). Welcome to the tidyverse. J. Open Source Softw. 4:1686. 10.21105/joss.01686</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.01686</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson G. N., Rogers C. E. (1973). Symbolic description of factorial models for analysis of variance. Appl. Stat. 22:392. 10.2307/2346786</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2346786</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams M. N., Grajales C. A. G., Kurkiewicz D. (2013). Assumptions of multiple regression: correcting two misconceptions. Pract. Assess. Res. Eval. 18 1&#x2013;14. 10.7275/55HN-WK47</Citation><ArticleIdList><ArticleId IdType="doi">10.7275/55HN-WK47</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasir S., Jin Y., Razzaq F. A., Rodriguez-Labrada R., Valdes-Sosa P. A., Bringas-Vega M. L., et al. (2023). The determinants of covid-induced brain disorders after covid-19 infection. Int. J. Psychophysiol. 188 134&#x2013;135. 10.1016/j.ijpsycho.2023.05.342</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpsycho.2023.05.342</ArticleId><ArticleId IdType="pmc">PMC10800467</ArticleId><ArticleId IdType="pubmed">38260018</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S. J. (2021). Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect. Dis. 53 737&#x2013;754. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida K., Bartel A. (2022). tableone: create &#x201c;Table 1&#x201d; to describe baseline characteristics with or without propensity score weights. Available online at: https://CRAN.R-project.org/package=tableone
(accessed April 10, 2023)</Citation></Reference><Reference><Citation>Zanon C., Hutz C. S., Yoo H., Hambleton R. K. (2016). An application of item response theory to psychological test development. Psicol. Reflex. Cr&#xed;t. 29:18. 10.1186/s41155-016-0040-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41155-016-0040-x</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>